D
Discovery Capital Management, LLC
+ を保有PURR
-6.03%
3か月リターン
$12.290
+2.860 (+23.27%)終値時点
Loading chart…
- 高値
- 12.330
- 始値
- 11.275
- 出来高加重平均価格
- 11.80
- 出来高
- 60.52M
- 時価総額
- —
- 安値
- 10.770
- 売買代金
- 713.97M
- EV/EBITDA（TTM）
- 0.37
Hyperliquid Strategies Inc is a digital asset treasury company. The Company is focused on accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. The Company’s subsidiary is Sonnet BioTherapeutics Holdings, Inc., which is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action.
AI分析 of Hyperliquid Strategies Inc (PURR)
買いHyperliquid Strategies Inc (PURR) is a good buy right now due to its recent stock buyback program expansion to $100 million, which signals strong confidence from the Board in the company's future. Additionally, the stock has shown impressive long-term performance with a 1-year change of +596.83%. However, the current RSI is at 29.95, indicating that the stock is oversold, which could present a buying opportunity. The main risk is the forward P/E ratio of 14.20, which suggests that the stock may be overvalued if future earnings do not meet expectations.
バリュエーション指標
Hyperliquid Strategies Inc（PURR）の現在の予想PERは3.22で、5年平均は13.39です。
PURR を保有するクジラ
イベントタイムライン
ニュース
- 8.510-29Fool
Hyperliquid Strategies Shares Surge 23.27% Following Major Announcements
8.510-29CNBCDruckenmiller Invests in New Decentralized Exchange
8.010-23PRnewswireHyperliquid Increases Stock Buyback Program to $100 Million
8.010-23NewsfilterHyperliquid Increases Stock Repurchase Program to $100 Million
9.510-23PRnewswireHyperliquid Strategies to Present Q3 Financial Results on November 5
PURR のよくある質問 — Alphio AI が回答
Hyperliquid Strategies Inc is a digital asset treasury company. The Company is focused on accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. The Company’s subsidiary is Sonnet BioTherapeutics Holdings, Inc., which is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action. It operates in the Technology sector.
Hyperliquid Strategies Inc (PURR) is a good buy right now due to its recent stock buyback program expansion to $100 million, which signals strong confidence from the Board in the company's future. Additionally, the stock has shown impressive long-term performance with a 1-year change of +596.83%. However, the current RSI is at 29.95, indicating that the stock is oversold, which could present a buying opportunity. The main risk is the forward P/E ratio of 14.20, which suggests that the stock may be overvalued if future earnings do not meet expectations.
コミュニティ
もっと見る ↗投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。